What is Biohaven's accrued liabilities, current?

Biohaven (BHVN) reported accrued liabilities, current of $41.65M in Q1 2026.

How has Biohaven's accrued liabilities, current changed year-over-year?

Biohaven's accrued liabilities, current decreased by 26.4% year-over-year, from $56.57M to $41.65M.

What is the long-term trend for Biohaven's accrued liabilities, current?

Over 4 years (2021 to 2025), Biohaven's accrued liabilities, current has grown at a 29.4% compound annual growth rate (CAGR), from $37.16M to $104.29M.

Biohaven BHVN Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Rapport Therapeutics, Inc.RAPP

——

uniQureQURE

——

Roivant SciencesROIV

——

Vera TherapeuticsVERA

——

AnaptysBio, Inc.ANAB

——

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's accrued liabilities, current?: Biohaven (BHVN) reported accrued liabilities, current of $41.65M in Q1 2026.
How has Biohaven's accrued liabilities, current changed year-over-year?: Biohaven's accrued liabilities, current decreased by 26.4% year-over-year, from $56.57M to $41.65M.
What is the long-term trend for Biohaven's accrued liabilities, current?: Over 4 years (2021 to 2025), Biohaven's accrued liabilities, current has grown at a 29.4% compound annual growth rate (CAGR), from $37.16M to $104.29M.